Real World & Advanced Analytics (RWAA)

Cytel’s HEOR & RWE team enables the world’s biotech and pharma companies to make confident evidence-based decisions to ensure successful outcomes. Powered by the unique experience and expertise of our researchers and consultants around the world, we conceptualize and execute HEOR and RWE studies, using advanced quantitative techniques to prepare sponsors for regulatory submission and to support their product’s clinical and economic value proposition. Our teams conduct evidence synthesis, economic analyses and comparative effectiveness studies to generate the evidence to support the overall value of a product, and our experts translate evidence into concise value propositions.